Preventing Risks in Veterans Treated with Prescription Opioids

Brief Description Of Study

The purpose of this study is to determine the effectiveness of text messaging and brief phone counseling to assist veterans in safe use of prescription opiates.

Clinical Study Identifier: TX1075

Detailed Study Description

Up to 300 veterans who are prescribed daily opiates for the treatment of chronic pain will be randomized into one of two groups: either Standard Care in which case they receive a standard brief intervention regarding alcohol use and prescription opiate use; or the Prevention Intervention in which the veteran will receive motivational text messages and brief telephone calls in addition to the standard brief intervention.

Additional Information About The Study

Veterans between the ages of 18 and 75 who are prescribed daily opiates for treatment of chronic pain, have a cell phone capable of receiving text messages, and drink alcohol, may be eligible for this study. Participation includes 6 research visits for which veterans will receive compensation for their time, as well as possibly receiving text messages and brief counseling calls. The first visit will last about three hours with subsequent visits being one hour. At each visit we will collect a urine sample for drug testing as well as a blood sample at the first and last visit for alcohol testing. Active intervention lasts for 12 months, and the final research follow up is at 18 months. This research is sponsored by the US Army Medical Research and Materiel Command (USAMRMC).

Contact research investigator to learn more about this study by filling out the form below.


To: Research Study Investigator
Subject: I am interested in participating in your Research Study
Dear Investigator,
I'm interested in learning more about and participating in your research study named: Preventing Risks in Veterans Treated with Prescription Opioids
I am hoping to hear back from you and discuss details of the study

By clicking "Contact Research Team", your contact information will be sent directly to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.